DEMETER EVPREP
LIVE

Serial Number

98769454

Owner

Exokeryx, Inc.

Attorney

John W. Olivo Jr.

Filing Date

Sep 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DEMETER EVPREP Trademark

Serial Number: 98769454

DEMETER EVPREP is a trademark filed by Exokeryx, Inc. on September 25, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Exokeryx, Inc. (4 trademarks)

3030 Bunker Hill St.
San Diego, CA 92109

Entity Type: 03

Trademark Details

Filing Date

September 25, 2024

Registration Date

Not Registered

Published for Opposition

November 25, 2025

Goods & Services

Kits comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffer solutions, nucleic acids, biological agents in the nature of microorganism cultures, assays, for scientific, non-medical, or medical research use; Kits comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffer solutions, nucleic acids, biological agents in the nature of microorganism cultures, and assays, conjugation chemistries, and chemical groups for scientific or medical research use; kits comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffer solutions, nucleic acids, biological agents in the nature of microorganism cultures, and assays, for scientific and research use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for scientific research

Kits comprised of reagents, enzymes, enzyme substrates, monoclonal antibodies, buffer solutions, nucleic acids, biological agents in the nature of microorganism cultures, assays, conjugation chemistries, and chemical groups for in vitro diagnostic use; kits comprised of reagents, enzymes, enzyme substrates, monoclonal antibodies, buffer solutions, nucleic acids, biological agents in the nature of microorganism cultures, assays, conjugation chemistries, and chemical groups for veterinary use; kits comprised of reagents, enzymes, enzyme substrates, monoclonal antibodies, buffer solutions, nucleic acids, biological agents in the nature of microorganism cultures, assays, conjugation chemistries, and chemical groups for medical clinical use; kits comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffer solutions, nucleic acids, biological agents in the nature of microorganism cultures, and assays, for medical use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, drug development, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, oncology, neurodegeneration, infectious disease for medical purposes

DNA, RNA, protein, lipid, metabolite, biomarker analysis services for scientific research purposes in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease; Providing on-line non-downloadable computer search engine software for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease; providing online nondownloadable computer software for the custom design and ordering of assays and reagents in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease; Scientific laboratory services; Medical research laboratory services; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of onsite management of information technology (IT) systems of others that allows users to store, analyze and share information over a global computer network in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease

Medical laboratory analysis services relating to the treatment of persons

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 20, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2025 REAP
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 7, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 7, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 9, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 1, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2025 NWOS
NEW APPLICATION ENTERED
Sep 25, 2024 NWAP